(S)-2-(4-(tert-Butyl)phenyl)-2-(methylamino)ethanol, 98%, 250mg

3-Methyloxazolidine, 95%, 100mg

2-(4-Bromo-3-fluorophenyl)ethanol, 98%, 100mg

2,6-Dibromo-4-fluoropyridine, 97%, 5g

1-(6,7-Dichloro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)ethanone, 95.0%, 250mg

1-(o-tolyl)cyclopropan-1-amine, 95%, 1g

2-Chloro-4,5-difluoro-3-nitrobenzoic acid, 95.0%, 5g

3-(Trichlorosilyl)propyl 2-Bromo-2-methylpropanoate>95.0%(GC)1g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane, 97%, 100g

3-Benzylthiazol-3-ium bromide, 98%, 250mg

2-CHLORO-N-3-PYRIDINYL-ACETAMIDE, 97%, 500mg

tert-Butyl (3-cyano-4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-7-fluorobenzo[b]thiophen-2-yl)carbamate, 98%, 100mg